These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients. Jackson CH; Sharples LD Stat Med; 2002 Jan; 21(1):113-28. PubMed ID: 11782054 [TBL] [Abstract][Full Text] [Related]
4. A stochastic estimation procedure for intermittently-observed semi-Markov multistate models with back transitions. Aralis H; Brookmeyer R Stat Methods Med Res; 2019 Mar; 28(3):770-787. PubMed ID: 29117850 [TBL] [Abstract][Full Text] [Related]
5. A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified. Benoit JS; Chan W; Luo S; Yeh HW; Doody R Stat Med; 2016 Apr; 35(9):1549-57. PubMed ID: 26782946 [TBL] [Abstract][Full Text] [Related]
6. Multistate models for the natural history of cancer progression. Cheung LC; Albert PS; Das S; Cook RJ Br J Cancer; 2022 Oct; 127(7):1279-1288. PubMed ID: 35821296 [TBL] [Abstract][Full Text] [Related]
7. Combining mixed effects hidden Markov models with latent alternating recurrent event processes to model diurnal active-rest cycles. Ren B; Barnett I Biometrics; 2023 Dec; 79(4):3402-3417. PubMed ID: 37017074 [TBL] [Abstract][Full Text] [Related]
8. A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data. Lange JM; Hubbard RA; Inoue LYT; Minin VN Biometrics; 2015 Mar; 71(1):90-101. PubMed ID: 25319319 [TBL] [Abstract][Full Text] [Related]
10. Semi-Markov Arnason-Schwarz models. King R; Langrock R Biometrics; 2016 Jun; 72(2):619-28. PubMed ID: 26584064 [TBL] [Abstract][Full Text] [Related]
11. A piecewise-homogeneous Markov chain process of lung transplantation. Sharples LD; Taylor GI; Faddy M J Epidemiol Biostat; 2001; 6(4):349-55. PubMed ID: 12036269 [TBL] [Abstract][Full Text] [Related]
12. A latent topic model with Markov transition for process data. Xu H; Fang G; Ying Z Br J Math Stat Psychol; 2020 Nov; 73(3):474-505. PubMed ID: 31912906 [TBL] [Abstract][Full Text] [Related]
13. Hierarchical continuous-time inhomogeneous hidden Markov model for cancer screening with extensive followup data. Meng R; Soper B; Lee HK; Nygård JF; Nygård M Stat Methods Med Res; 2022 Dec; 31(12):2383-2399. PubMed ID: 36039541 [TBL] [Abstract][Full Text] [Related]
14. Regularized continuous-time Markov Model via elastic net. Huang S; Hu C; Bell ML; Billheimer D; Guerra S; Roe D; Vasquez MM; Bedrick EJ Biometrics; 2018 Sep; 74(3):1045-1054. PubMed ID: 29534304 [TBL] [Abstract][Full Text] [Related]
15. Group-representative functional network estimation from multi-subject fMRI data via MRF-based image segmentation. Tang B; Iyer A; Rao V; Kong N Comput Methods Programs Biomed; 2019 Oct; 179():104976. PubMed ID: 31443856 [TBL] [Abstract][Full Text] [Related]
18. Analysis of panel data under hidden mover-stayer models. Yi GY; He W; He F Stat Med; 2017 Sep; 36(20):3231-3243. PubMed ID: 28766830 [TBL] [Abstract][Full Text] [Related]
19. A review of multistate modelling approaches in monitoring disease progression: Bayesian estimation using the Kolmogorov-Chapman forward equations. Matsena Zingoni Z; Chirwa TF; Todd J; Musenge E Stat Methods Med Res; 2021 May; 30(5):1373-1392. PubMed ID: 33826459 [TBL] [Abstract][Full Text] [Related]
20. Hidden Markov models for the stimulus-response relationships of multistate neural systems. Escola S; Fontanini A; Katz D; Paninski L Neural Comput; 2011 May; 23(5):1071-132. PubMed ID: 21299424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]